investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
The role of the SF3B1 splicing factor in chronic lymphocytic leukemia
Catherine Ju-Ying Wu
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Catherine Ju-Ying Wu
Dana-Farber Cancer Institute
Boston, United States
Related projects
John D Schuetz
Metabolic pathways in leukemia
Leukaemia
Marina Y Konopleva
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
Leukaemia
Tracy G Anthony
Molecular Mechanisms of Adverse Metabolic Events by Asparaginase.
Leukaemia
Pediatric oncology or childhood cancer
Kimberly Stegmaier
Validating Syk as a Target for AML Therapy
Leukaemia
Gerd P Pfeifer
5-hydroxymethylcytosine in Human Cancer
Leukaemia
Charles G Mullighan
Functional analysis of leukemic CREBBP mutations
Leukaemia
Pediatric oncology or childhood cancer
Peter Aplan
Collaborative Pathways that Lead to Leukemia
Leukaemia
Pathology
Hematology and hematologic malignancies
Richard A Flavell
Understanding Hemotopoietic Neoplasias using Humanized Mice
Leukaemia
Pathology
Hematology and hematologic malignancies
Xuefang Cao
Targeting Granzyme B to Separate GVH from GVL Responses
Leukaemia